Some of the upstream regulators are involved in tumor metastasis, such as beta-estradiol, MYCN, and IL1B, which can modulate the progression of steroid-sensitive breast cancers [44], promote the proliferation of non-small cell lung cancer [45] and drive metastasis and colonization of the bone microenvironment, respectively. Here, MYCN is linked to non-small cell lung carcinoma.